Members Give Homepage Donor FAQs   Marketing Resources Your Account    Giving Basket
Members Give Homepagepowered by GuideStar

National Brain Tumor Society, Inc.

Also Known As: NBTS
55 Chapel Street 
Suite 200
Newton,  MA  02458

GENERAL INFORMATION

  • This organization is a 501(c)(3) Public Charity.
  • Financial information in this report is derived from the organization's December 31, 2015 Form 990.

Web Site

http://www.braintumor.org

Chief Executive Profile

David Arons is the Chief Executive Officer of National Brain Tumor Society. He also serves as the National Brain Tumor Society's Chief Public Policy and Advocacy Officer. He previously served as the Director of Government Relations for the American Cancer Society in Minnesota and was the co-founder and Co-Director of the Center for Lobbying in the Public Interest. He is the author of several books, including Power in Policy: A Funder's Guide to Advocacy and Civic Participation, Strengthening Nonprofit Advocacy, and A Voice for Nonprofits. He serves on the National Cancer Institute's Council of Research Advocates and Clinical Trials Advisory Committee.


MISSION AND PROGRAMS

Mission

National Brain Tumor Society is fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and anyone who will be diagnosed tomorrow. Our goal is to make brain tumors a chronic, manageable disease by the year 2025. We have a rigorous and thoughtful agenda, integrating research and public policy to bridge critical gaps. Starting with discovery science, to clinical trial design and the development of new therapies, there are many opportunities to make improvements and speed the momentum of new findings.

Programs

Program:Public Policy and Advocacy
Budget: NaN
Category: None
Population Served: General Public/Unspecified

Program Description:

National Brain Tumor Society works with volunteer advocates in the brain tumor community to fight for resources and policies that will result in better treatments and better quality of life for those affected by brain tumors. Through public policy, we are fighting to: Strengthen research Advance therapies Improve health care


Program:Research
Budget: NaN
Category: None
Population Served: None

Program Description:

National Brain Tumor Society (NBTS) drives research along the entire continuum of the drug discovery and development pipeline, with a singular focus – to find a cure for brain tumors. To support this commitment: We fund only the most imminently promising projects for brain tumors. We seek researchers dedicated to the areas of greatest need. We demand research approaches, which will deliver compelling results. With these guiding principles, our funded programs achieve thoughtful and strategic investments across the entire research spectrum, from basic science to clinical trials. By collaborating with the world's most prestigious institutions and researchers, we drive research to therapy seeking those projects with the scientific potential to reach clinical trial, as well as advance research progress for all brain tumors. With targeted programs in systems biology, pediatric brain tumors, and other emerging research areas, we are leading a community devoted to providing access to better care and new treatments, as well as expediting the discovery of a cure. Since our inception, we have awarded more than $26 million in research grants. Today, our grant structure represents a comprehensive and distinct model, which is effective for both academic and industry researchers.


Balance Sheet Fiscal Year Ending December 31, 2015

Total Note: The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities also must be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.
Assets January 1, 2015December 31, 2015Change
Cash & Equivalent$1,014,436$798,586($215,850)
Accounts Receivable$4,046$0($4,046)
Pledges & Grants Receivable$1,007,915$686,515($321,400)
Receivable/Other Due to changes in the 2008 Form 990, this data is no longer reported.$0$0$0
Inventories for Sale or Use$0$0$0
Investment/Securities Due to Changes in the 2008 Form, this value now includes Publicly Traded Securities as well as Other Securities. $1,640,680$1,181,363($459,317)
Investment/Other Due to various changes in the way this data is reported in the 2008 Form 990, it may not be possible to accurately compare this data from the 2008 form 990 against the same field on prior forms $0$0$0
Fixed Assets The 2008 form does not distinguish between LBE as investments and LBE as fixed assets. This value is equivalent to the sum of both line items on earlier forms (Part IV line 55 plus line 57). $165,099$54,266($110,833)
Other Program Related Investments is now a separate field on the new form, Part X-13(A) and (B). $460,904$109,851($351,053)
Total Assets:$4,293,080$2,830,581($1,462,499)

LiabilitiesJanuary 1, 2015December 31, 2015Change
Accounts Payable$577,691$617,644$39,953
Grants Payable$2,313,747$1,986,269($327,478)
Deferred Revenue$45,396$40,000($5,396)
Loans and Notes The value on this line may now include payables to former employees, disqualified persons and unrelated third parties. $0$0$0
Tax-Exempt Bond Liabilities$0$0$0
Other Due to various changes in the way this data is reported in the 2008 Form 990, it may not be possible to accurately compare this data from the 2008 Form 990 against the same field on prior forms $397,000$0($397,000)
Total Liabilities:$3,333,834$2,643,913($689,921)

Fund Balance:$959,246$186,668($772,578)
 


 
 

Basic Information

 
 
EIN:04-3068130
Chief Executive:Mr. David Arons
Contact: Mr. Michael Antonellis, National Director of Marketing Communications
Telephone: 617 -393-2841
Fax: 617 -9249998
E-mail: mantonellis@braintumor.org
Ruling Year: 1994
Fiscal Year End Date: December 31, 2015
Assets: $2,830,581
(from Dec 31, 2015 Form 990)
Income: $7,247,633
(from Dec 31, 2015 Form 990)
 
 

Copyright , GuideStar USA, Inc. All Rights Reserved. | Policies | Standards for Internet Philanthropy

GuideStar is the registered trademark and operating name of GuideStar USA, Inc., a 501(c)(3) nonprofit organization.

Any other use, including resale of the information or use for commercial gain, is prohibited, except in accordance with a GuideStar licensing agreement.